Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2010
11/09/2010US7829583 Biphenyl derivatives
11/09/2010US7829572 Hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy; e.g. (R)-3-(1-(3,4-difluorophenyl) propan-2-yl)-2-(3-hydroxypyridin-2-yl) 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one
11/09/2010US7829568 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010CA2496164C Benzimidazole quinolinones and uses thereof
11/09/2010CA2434937C Phenyl derivatives
11/04/2010WO2010126881A1 Processes and intermediates
11/04/2010WO2010126851A1 Cxcr3 receptor antagonists
11/04/2010WO2010126745A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010125985A1 Fused heterocyclic compound and use thereof
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125469A1 Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
11/04/2010WO2010125343A1 Compounds for inducing cellular apoptosis
11/04/2010WO2010124619A1 1,2,3-3h pyridine heterocyclic compounds, their agricultural compositions, their use and their preparation methods
11/04/2010WO2010092111A3 Compounds for non-invasive measurement of aggregates of amyloid peptides
11/04/2010WO2010059503A3 PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF
11/04/2010US20100280240 Bicyclic pyrazole compounds as antibacterial agents
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280063 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
11/04/2010US20100280058 Spirocyclic heterocyclic derivatives and methods of their use
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280043 Pyrazolopyridines as kinase inhibitors
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280021 Pyridopyrimidine protein tyrosine phosphatase inhibitors
11/04/2010US20100280012 Azaazulene compounds
11/04/2010US20100280010 Chemical compounds
11/04/2010US20100280002 Aminopyridine-derivatives as inductible no-synthase inhibitors
11/04/2010US20100280001 Imidazoquinolines with immuno-modulating properties
11/04/2010US20100278835 Novel compounds 660
11/04/2010US20100278833 Thiophene-imidazopyridines
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100277063 Fluorene-based derivative and organic electroluminescence device employing the same
11/04/2010US20100275390 Compounds of azomethine type comprising a cationic pyrazolopyridine unit, for dyeing keratin fibres
11/04/2010CA2760541A1 Pyrido[4,3-b] indoles and methods of use
11/04/2010CA2760163A1 Processes and intermediates
11/04/2010CA2758958A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors
11/03/2010EP2246394A1 Fluoride-substituted perylenes for colour filters in LCD
11/03/2010EP2246352A1 Novel diazabicyclic aryl derivatives and their medical use
11/03/2010EP2246351A1 Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device
11/03/2010EP2246350A1 Fluoride-substituted perylenes for colour filters in LCD
11/03/2010EP2246346A1 Indolylmaleimide derivatives as protein kinase inhibitors
11/03/2010EP2246345A1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/03/2010EP2246038A1 Azomethinic cationic pyrazolidine derivatives for dyeing keratin fiber
11/03/2010EP2245030A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
11/03/2010EP2245028A1 5-aminocyclylmethyl-oxazolidin-2-one derivatives
11/03/2010EP2245014A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/03/2010EP2244711A1 Certain chemical entities, compositions and methods
11/03/2010EP2244708A1 NEW 2,3,4,5-TEtRAHYDRO-1H-PYRIDO [4,3-B] INDOLE COMPOUNDS AND METHODS OF USE THEREOF
11/03/2010EP1954274B1 Substituted quinolones and methods of use
11/03/2010EP1869036B1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
11/03/2010EP1846406B1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
11/03/2010EP1781667B1 Benzothienopyridines for use as inhibitors of eg5 kinesin
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/03/2010CN1950370B Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives
11/03/2010CN101878214A Benzomorphan compounds
11/03/2010CN101878213A Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
11/03/2010CN101878212A Triazolopyridine compounds and their use as ask inhibitors
11/03/2010CN101878208A Substituted-quinoxaline-type-piperidine compounds and the uses thereof
11/03/2010CN101878204A Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/03/2010CN101875658A Preparation method of 3-carbonyl-2,8-diazepine helix[4.5]decane-8-carboxylic acid tert-butyl ester
11/03/2010CN101875657A Application of tylophorine-type alkaloid organic acidic salt derivatives in pesticide
11/03/2010CN101875653A Preparation and application of 1,2,3-3H pyridine-heterocyclic compound
11/03/2010CN101184487B Bicyclic pyrazole compounds as antibacterial agents
11/03/2010CN101098870B Novel fused imidazole derivative
11/02/2010US7825242 Immunosuppressants; autoimmune diseases; antiinflammatory agents;antiarthritic agents; aids
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825124 Indolylmaleimide derivatives
11/02/2010US7825119 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate
11/02/2010US7825118 4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives; can be covalently bonded to Bruton's tyrosine kinase; autoimmune diseases, lymphoma, leukemia; antiproliferative, anticarcinogenic and antiinflammatory agents
11/02/2010US7825114 Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
11/02/2010CA2600510C Crystal forms of an imidazole derivative
11/02/2010CA2545527C Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
11/02/2010CA2485201C Camptothecins with a modified lactone ring
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2405741C Sodium salt of an azo derivative of 5-aminosalicylic acid
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010124005A1 Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
10/28/2010WO2010123583A2 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof
10/28/2010WO2010123131A1 Metal complex having aromatic ligand that contains nitrogen atom
10/28/2010WO2010123115A1 Process for production of 2-azaadamantane compound from bicyclocarbamate compound
10/28/2010WO2010123049A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010WO2010123046A1 Modified metal complex
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010122774A1 Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof
10/28/2010WO2010122576A1 Improved process for the preparation of 6-methyl-2-[4-methyl phenyl] imidazo [1, 2-a] pyridine-3-n, n-dimethyl acetamide.
10/28/2010WO2010122575A2 Process for the preparation of pure paliperidone
10/28/2010WO2010122272A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
10/28/2010WO2010122064A1 Substituted naphthyridine derivatives and their medical use
10/28/2010WO2010121995A1 3,3'-spiroindolinone derivatives and their use for cancer
10/28/2010WO2010121646A1 Heterocyclic compounds as mek inhibitors
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100274020 Process for the preparation of pharmaceutical intermediates
10/28/2010US20100274017 Processes for the preparation of sitagliptin and pharmaceuticlly acceptable salts thereof
10/28/2010US20100274013 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 646